OTCQB: PHRRF | CSE: PHRM
PharmaTher Holdings Ltd. Ketamine
  • HOME
  • COMPANY
    • Management
    • Board Of Directors
  • PIPELINE
    • KETARX Ketamine
  • INVESTORS
  • NEWS
  • CONTACT
  • HOME
  • COMPANY
    • Management
    • Board Of Directors
  • PIPELINE
    • KETARX Ketamine
  • INVESTORS
  • NEWS
  • CONTACT

Press Releases

11/30/2021

PharmaTher Granted New Japanese Patent for KETABET™  (Ketamine Combination Formulation), Strengthening Global Patent Portfolio

 

Read More

11/24/2021

PharmaTher Applies for FDA Orphan Drug Designation for Ketamine to Treat Rare Neurological Disorder Status Epilepticus

 

Read More

11/11/2021

PharmaTher Announces Positive Research Results for Psilocybin Microneedle Patch

 

Read More

11/3/2021

PharmaTher Enters into Research Collaboration Agreement with Revive Therapeutics for Development of Psilocybin Microneedle Patch

 

Read More

11/1/2021

PharmaTher Provides Research Update on Microneedle Patch Delivery Technologies for Psychedelics

 

Read More

    Archives

    September 2024
    August 2024
    May 2024
    April 2024
    February 2024
    January 2024
    September 2023
    July 2023
    June 2023
    May 2023
    March 2023
    February 2023
    January 2023
    December 2022
    November 2022
    October 2022
    September 2022
    July 2022
    June 2022
    May 2022
    April 2022
    March 2022
    February 2022
    January 2022
    December 2021
    November 2021
    October 2021
    September 2021
    August 2021
    July 2021
    June 2021
    May 2021
    April 2021
    March 2021
    February 2021
    January 2021
    December 2020
    November 2020
    October 2020

    Categories

    All

    RSS Feed

Psychedelic Pharmaceuticals
© COPYRIGHT 2024.  PharmaTher Holdings Ltd.   ALL RIGHTS RESERVED.